Ginkgo biloba survived 270 million years. It survived mass extinction events that eliminated most of what coexisted with it. Individual trees live for over 1000 years. Ginkgo trees within 1 to 2 kilometers of the Hiroshima atomic bomb hypocenter survived when virtually every other large living thing in that radius did not. This is not coincidence — it is a plant that figured out cellular protection at an evolutionary level unmatched in the botanical world. And the compounds responsible for that extraordinary resilience are the same compounds that make the leaf extract one of the most consistently documented cognitive and vascular botanicals in modern medicine.
Two Compound Classes, Two Mechanisms
Standardized ginkgo extract contains flavonoid glycosides (24 percent) — the antioxidant fraction providing endothelial protection, cerebral vasodilation, and free radical scavenging — alongside terpene lactones (6 percent) including ginkgolides unique to ginkgo in the entire plant kingdom. Ginkgolide B is a potent antagonist of platelet-activating factor (PAF), a phospholipid mediator involved in platelet aggregation, immune inflammation, and smooth muscle contraction. PAF antagonism reduces micro-platelet aggregation in cerebral microvasculature, improving capillary perfusion to neural tissue. No other plant produces these compounds. This is genuine molecular uniqueness.
The Cognitive Evidence
Controlled trials using standardized EGb761 ginkgo extract have demonstrated improvements in memory, processing speed, and attention, with the most consistent evidence in individuals with age-related cognitive changes. The mechanisms are clear: more cerebral blood flow, less cerebrovascular inflammation, direct neuronal protection from bilobalide. The tree that survived everything figured out cellular resilience. The leaf extract transfers some of that resilience to the nervous system that uses it. Two hundred and seventy million years is a long time to be right about something.